AbbieLFieldsMD

PubMed

• 4 citations
  Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: A clinicopathologic study of 84 patients originally classified as FIGO stage II
  Jeffrey D. Seidman, Jonathan A. Cosin, Brant G. Wang, Skylar Alsop, Anna Yemelyanova, Abbie L. Fields, Charles R. Boice, Richard J. Zaino> ;Gynecologic Oncology. 2010 Nov 1
• Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
  Abbie L. Fields, Mark H. Einstein, Akiva P. Novetsky, Juliana Gebb, Gary L. Goldberg> ;Gynecologic Oncology. 2008 Jan 1
• 16 citations
  Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally adva...
  Akiva P. Novetsky, Mark H. Einstein, Gary L. Goldberg, Susan M. Hailpern, Evan Landau, Abbie L. Fields, Subhakar Mutyala, Shalom Kalnicki, Madhur K. Garg> ;Gynecologic Oncology. 2007 Jun 1
• Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer.
  Mark H. Einstein, Akiva P. Novetsky, Madhur K. Garg, Susan M. Hailpern, Gloria S. Huang, Arielle Glueck, Abbie L. Fields, Shalom Kalnicki, Gary L. Goldberg> ;Cancer. 2007 Jan 1
• 16 citations
  Total pelvic exenteration: The Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)
  Gary L. Goldberg, Paniti Sukumvanich, Mark H. Einstein, Harriet O. Smith, Patrick Anderson, Abbie L. Fields> ;Gynecologic Oncology. 2006 May 1
• 1 citations
  Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: a brief communication from the New York Phase II consortium.
  D. Yi Shin Kuo, Patrick F. Timmins, Stephanie V. Blank, Abbie L. Fields, Gary L. Goldberg, Anthony J. Murgo, Paul J. Christos, Scott Wadler, Carolyn D. Runowicz> ;Gynecologic Oncology. 2006 Jan 1
• 14 citations
  A phase I safety and dose escalation trial of docetaxel combined with GEM®231, a second generation antisense oligonucleotide targeting protein kinase A R1α in patients...
  Sanjay Goel, Kavita K. Desai, Manuel Macapinlac, Scott Wadler, Gary L. Goldberg, Abbie L. Fields, Mark H. Einstein, Fabio Volterra, Benny Wong, R. Russell Martin, Srid...> ;Investigational New Drugs. 2005 Jul 20
• How Often Should a Port-A-Cath be Flushed?
  Y. S. Kuo, Benjamin M. Schwartz, J. Santiago, Patrick Anderson, Abbie L. Fields, Gary L. Goldberg> ;Cancer Investigation. 2005 Jan 1
• A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit α of protein kinase A using a continuous infusion schedule in patie...
  Sanjay Goel, K. Desai, A. Bulgaru, Abbie L. Fields, Gary L. Goldberg, Sudhir Agrawal, R. Russell Martin, Michael Grindel, Sridhar Mani> ;Clinical Cancer Research. 2003 Sep 15
• 3 citations
  Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
  Brij M. Sood, Joan G. Jones, Sajel Gupta, Dineo Khabele, Chandan Guha, Carol Runowicz, Gary L. Goldberg, Abbie L. Fields, Patrick Anderson, B. Vikram> ;International Journal of Radiation Oncology Biology Physics. 2003 Sep 1
• 1 citations
  Evaluation of low-dose intraperitoneal interferon-α for palliation of ascites in patients with non-ovarian gynecologic malignancies
  Dineo Khabele, Carolyn D. Runowicz, Abbie L. Fields, Patrick Anderson, Gary L. Goldberg> ;Gynecologic Oncology. 2003 Jun 1
• 5 citations
  Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
  Brij M. Sood, Giridhar R. Gorla, Madhur Garg, Patrick S. Anderson, Abbie L. Fields, Carolyn D. Runowicz, Gary L. Goldberg, Bhadrasain Vikram> ;Cancer. 2003 Apr 1
• 18 citations
  Current therapies in ovarian cancer.
  Fields, A. L., Runowicz, C. D.> ;Cancer investigation. 2003 Mar 20
• 4 citations
  Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
  Brij Sood, Giridhar R. Gorla, Sajel Gupta, Madhur K. Garg, S. M. Deore, Carolyn D. Runowicz, Abbie L. Fields, Gary L. Goldberg, Patrick Anderson, Bhadrasain Vikram> ;International Journal of Radiation Oncology Biology Physics. 2002 Jul 1
• 7 citations
  Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous ce...
  Jonathan J. Beitler, Patrick Anderson, H. Haynes, Brij Sood, Abbie L. Fields, Gary L. Goldberg, Bhadrasain Vikram, Carolyn D. Runowicz, Scott Wadler> ;International Journal of Radiation Oncology Biology Physics. 2002 Mar 1
• 7 citations
  Allelotype of papillary serous peritoneal carcinomas.
  Ilana Cass, Rae Lynn Baldwin, Ella Fasylova, Abbie L. Fields, H.P. Klinger, Carolyn D. Runowicz, Beth Y. Karlan> ;Gynecologic Oncology. 2001 Jul 1
• 5 citations
  Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.
  Ilana Cass, Andrew J. Li, Carolyn D. Runowicz, Abbie L. Fields, Gary L. Goldberg, R.S. Leuchter, Leo D. Lagasse, Beth Y. Karlan> ;Gynecologic Oncology. 2001 Jan 1
• 169 citations
  BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
  Roxana Moslehi, William Chu, Beth Y. Karlan, David A. Fishman, Harvey A. Risch, Abbie L. Fields, David Smotkin, Yehuda Ben-David, Jacalyn Rosenblatt, Donna Russo, Pete...> ;American Journal of Human Genetics. 2000 Apr 1
• 1 citations
  Ovarian Carcinoid: Management of Primary and Recurrent Tumors
  Patrick F. Timmins, Dennis Yi-Shin Kuo, Patrick Anderson, Abbie L. Fields, Kathleen Whitney, Gary L. Goldberg> ;Gynecologic Oncology. 2000 Jan 1
• Screening for gynecologic malignancies: A continuing responsibility.
  Carolyn D. Runowicz, Abbie L. Fields> ;Surgical Oncology Clinics of North America. 1999 Oct 1
• Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.
  Patrick Anderson, Harriet O. Smith, Joan G. Jones, Gary L. Goldberg, Abbie L. Fields, Carolyn D. Runowicz, Jeffrey W. Pollard> ;Gynecologic Oncology. 1999 Aug 1
• Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group.
  Scott Wadler, Edward L. Schwartz, Patrick Anderson, Carolyn D. Runowicz, Linus Chuang, Giuseppe Del Priore, Howard S. Hochster, Gary L. Goldberg, Abbie L. Fields, Gord...> ;The cancer journal from Scientific American. 1999 May 1
• Unavoidable outcomes vs misadventures. Autopsy Committee of the College of American Pathologists.
  Davis A, Fields A, Hill C, Hanzlick R> ;Arch. Intern. Med.. 1999-04-12
• Compliance with Papanicolaou smear screening following tubal ligation in women with cervical cancer.
  Harvey A. Winkler, Patrick Anderson, Abbie L. Fields, Carolyn D. Runowicz, Carol DeVictoria, Gary L. Goldberg> ;Journal of Womens Health. 1999 Jan 1
• PSC833: initial clinical results in refractory ovarian cancer patients.
  Abbie L. Fields, Hochster H, Carolyn D. Runowicz, J Speyer, G. Goldberg, C Cohen, Dottino P, Scott Wadler, Berk G, Gretz H, John F. Mandeli, Holland J, Letvak L> ;Current Opinion in Oncology. 1998 Aug 1
• Join now to see all